Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-10

Clinical Trial Update: Routine Versus Symptomatic Protein Pump Inhibitor Therapy for Prevention of Gastroesophageal Reflux After Per Oral Endoscopic Myotomy for Esophageal Achalasia [NA]

View source ↗

Summary

A clinical trial update indicates recruitment is ongoing to compare routine versus symptomatic proton pump inhibitor therapy to prevent gastroesophageal reflux …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Proton Pump Inhibitors

Snippet

Sponsor: Centre Hospitalier Universitaire de Nīmes | Conditions: Esophageal Achalasia | NA | Status: RECRUITING